Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FX15B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,663
Award facts
- Contract value 100% obligated
- $3,662.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes on July 14, 2025, with a contract ceiling value of $3,662.95. This order is not set-aside and was competitively awarded under a firm fixed-price arrangement, with an ultimate completion date of July 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that fulfills critical medical procurement needs for federal agencies, particularly the Department of Defense and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery order for Actemra, a specialty medication, exemplifies the company's role in supplying specialized pharmaceutical products to support military and federal healthcare operations worldwide through the DLA's comprehensive pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FX15B?
SPE2DB25FX15B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FX15B worth?
The government has obligated $3,663 on SPE2DB25FX15B.
Is contract SPE2DB25FX15B an order under another contract?
Yes. SPE2DB25FX15B is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX15B competed?
The extent of competition for SPE2DB25FX15B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award